comparemela.com

Page 32 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioCardia, Inc (NASDAQ:BCDA) Sees Significant Drop in Short Interest

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 27,300 shares, a decrease of 84.0% from the July 15th total of 171,000 shares. Based on an average trading volume of 101,600 shares, the […]

Nektar Therapeutics (NASDAQ:NKTR) Rating Reiterated by Mizuho

Nektar Therapeutics (NASDAQ:NKTR) Rating Reiterated by Mizuho
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

APA Co (NASDAQ:APA) Given Average Rating of Moderate Buy by Brokerages

APA Co. (NASDAQ:APA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation, eight have assigned a buy recommendation and one […]

National Bank Financial Brokers Reduce Earnings Estimates for Centerra Gold Inc (NYSE:CGAU)

Centerra Gold Inc. (NYSE:CGAU – Free Report) – Research analysts at National Bank Financial dropped their FY2023 earnings per share estimates for Centerra Gold in a report issued on Tuesday, August 1st. National Bank Financial analyst M. Parkin now anticipates that the company will post earnings per share of $0.00 for the year, down from […]

Coherus BioSciences (NASDAQ:CHRS) Given New $20 00 Price Target at HC Wainwright

Coherus BioSciences (NASDAQ:CHRS – Free Report) had its price target trimmed by HC Wainwright from $24.00 to $20.00 in a research report sent to investors on Thursday, MarketBeat reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Barclays […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.